HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Festuclavine

HCID 332915
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
569-26-6
Standard SMILES
C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
InChIKey
VLMZMRDOMOGGFA-WDBKCZKBSA-N
Molecular formula
C16H20N2
Average molar mass
240.34 g/mol
Monoisotopic mass
240.16264865

Overview

Festuclavine is an alkaloid that is the 6,8beta-dimethyl derivative of ergoline. It is a conjugate base of a festuclavine(1+). It derives from a hydride of an ergoline.

Names & identifiers

Preferred name
Festuclavine
IUPAC
(6aR,9R,10aR)-7,9-dimethyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline
English name
6,8β-Dimethylergoline
Molecular formula
C16H20N2
Molecular weight
240.34

Names & synonyms

Festuclavine6,8-beta-Dimethylergoline569-26-6D-6,8-Dimethylergoline-I(8-beta)-6,8-DimethylergolineENO1(8beta)-6,8-dimethylergoline88ZK48D2QGNSC-332446Ergoline, 6,8beta-dimethyl-CHEBI:65035DTXSID00205432
Show more names
6,8β-DimethylergolineErgoline, 6,8-dimethyl-, (8β)-
Ergoline, 6,8-dimethyl-, (8beta)-(6aR,9R,10aR)-7,9-dimethyl-6,6a,8,9,10,10a-hexahydro-4H-indolo(4,3-fg)quinoline(6aR,9R,10aR)-7,9-dimethyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolineRefChem:1085365DTXCID00127923FestuclavinCHEMBL138666,8beta-dimethylergoline

Database identifiers

CAS
569-26-6
PubChem CID
332915
DTXSID
DTXSID00205432
ChEMBL
CHEMBL13866
ChEBI
CHEBI:65035
UNII
88ZK48D2QG
Nikkaji
J128.602A

Properties

Computed structural propertiesFilling in

XLogP
3.2
Topological polar surface area
19 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
0
Heavy atoms
18
Formal charge
0
Complexity
329

Physicochemical properties

FDA UNII
88 ZK48D2QG · 88ZK48D2QG

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Treatment · 1 item

Treatment for ergotism consists of vasodilators, anticoagulants and low molecular weight dextrans. If necessary, a sympathetic nerve blockade may be carried out, such as brachial plexus blockade. Temporary sedation (e.g. haloperidol) will be necessary in hallucination and diazepam is used for convulsions. There is no specific antidote. (L1921)

Health EffectsIngestion of ergoline alkaloids is known to cause the disease ergotism. Ergotism occurs in two forms, gangrenous and convulsive, likely depending on the different kinds and amounts of ergoline alkaloids present. (A2913)
Exposure RoutesOral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)
Toxicity Summary · 1 item

Ergoline alkaloids tend to act as a group, producing complex and variable effects of partial agonism or antagonism at adrenergic, dopaminergic, and serotonergic receptors. Variables relating to these effects are influenced by the agent, dosage, species, tissue, physiological, and endocrinological state, and experimental conditions. In particular, ergoline alkaloids have been shown to have the significant affinity towards the 5-HT1 and 5-HT2 serotonin receptors, D1 and D2 dopamine receptors, and alpha-adrenergic receptors. This can result in a number of different effects, including vasoconstriction, convulsions, and hallucinations. (A2914, A2915, A2916)

Signs and Symptoms · 1 item

Convulsive ergotism can cause painful seizures and spasms, diarrhea, paresthesias, itching, headaches, nausea and vomiting. Usually the gastrointestinal effects precede the central nervous system effects. As well as seizures there can be hallucinations and mental effects including mania or psychosis. Gangrenous ergotism causes dry gangrene as a result of vasoconstriction induced in the more poorly vascularized distal structures, such as the fingers and toes. Symptoms include desquamation, weak periphery pulse, loss of peripheral sensation, edema and ultimately the death and loss of affected tissues. (L1920)

Chemistry & industry

Uses & manufacturing

Uses · 1 item

Costaclavine is a naturally occuring alkaloid of the ergoline family. As it is derived from dimethylergoline, it is referred to as a clavine. Like other ergoline alkaloids, it occurs in various species of vines of the Convolvulaceae (morning glory) family and in some species of lower fungi. (L1918)

Additional notes

DefinitionChEBI: An alkaloid that is the 6,8beta-dimethyl derivative of ergoline.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).